WallStreetZenWallStreetZen

NASDAQ: BNTC
Benitec Biopharma Inc Stock Ownership - Who owns Benitec Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Benitec Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Suvretta Capital Management LLCDirector2025-12-2911,587$13.44
$155.73kBuy
Suvretta Capital Management LLCDirector2025-12-2965,800$13.44
$884.35kBuy
Suvretta Capital Management LLCDirector2025-12-262,516$13.10
$32.96kBuy
Suvretta Capital Management LLCDirector2025-12-2614,320$13.10
$187.59kBuy
Suvretta Capital Management LLCDirector2025-12-2342,600$12.85
$547.41kBuy
Suvretta Capital Management LLCDirector2025-12-237,400$12.85
$95.09kBuy
Suvretta Capital Management LLCDirector2025-12-222,892$12.08
$34.94kBuy
Suvretta Capital Management LLCDirector2025-12-2216,650$12.08
$201.13kBuy
Suvretta Capital Management LLCDirector2025-12-1913,950$11.48
$160.15kBuy
Suvretta Capital Management LLCDirector2025-12-192,434$11.48
$27.94kBuy

1 of 2

BNTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BNTC insiders and whales buy or sell their stock.

BNTC Shareholders

What type of owners hold Benitec Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC33.62%11,548,351$135.69MInstitution
Janus Henderson Group PLC8.48%2,911,688$34.21MInstitution
Franklin Resources Inc6.40%2,197,305$25.82MInstitution
Adage Capital Partners GP LLC6.17%2,120,672$24.92MInstitution
Suvretta Capital Management LLC6.02%2,069,267$24.31MInsider
Ra Capital Management LP5.39%1,850,000$21.74MInstitution
Vanguard Group Inc3.42%1,174,758$13.80MInstitution
Nantahala Capital Management LLC3.02%1,038,371$12.20MInstitution
Blackrock Inc2.89%992,347$11.66MInstitution
Infinitum Asset Management LLC2.62%898,871$10.56MInstitution

1 of 3

BNTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BNTC91.68%8.32%Net BuyingNet Buying
MNPR22.32%77.68%Net SellingNet Selling
ZURA44.38%55.62%Net BuyingNet Buying
LCTX39.96%60.04%Net SellingNet Selling
IMMP0.13%0.00%
View Top Biotech Stocks

Benitec Biopharma Stock Ownership FAQ

Who owns Benitec Biopharma?

Benitec Biopharma (NASDAQ: BNTC) is owned by 92.16% institutional shareholders, 8.36% Benitec Biopharma insiders, and 0.00% retail investors. Suvretta Capital Management LLC is the largest individual Benitec Biopharma shareholder, owning 2.07M shares representing 6.02% of the company. Suvretta Capital Management LLC's Benitec Biopharma shares are currently valued at $24.31M.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.